drugset / Trial / NCT00650091

Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF

NCT00650091

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Idiopathic pulmonary fibrosis (IPF) is a long-term lung disease that affects an individual's ability to breathe. In this randomized, double-blind, placebo-controlled trial, we assigned patients with idiopathic pulmonary fibrosis who had mild-to-moderate lung-function impairment to one of three groups - receiving a combination of prednisone, azathioprine, and NAC (combination therapy), NAC alone, or placebo - in a 1:1:1 ratio.

Timeline

Start
2009-10
Primary completion
2013-10
Completion
2014-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator N-acetylcysteine Small molecule 600 mg